ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 193 filers reported holding ANIKA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 13.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $411,000 | -46.9% | 11,615 | -43.4% | 0.09% | -44.2% |
Q2 2020 | $774,000 | -17.8% | 20,524 | -37.0% | 0.15% | +5.5% |
Q1 2020 | $942,000 | -86.2% | 32,599 | -75.2% | 0.15% | -77.6% |
Q4 2019 | $6,816,000 | -34.6% | 131,465 | -30.8% | 0.65% | -17.4% |
Q3 2019 | $10,428,000 | +753.4% | 189,980 | +531.4% | 0.79% | +806.9% |
Q2 2019 | $1,222,000 | – | 30,089 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |